All Title Author
Keywords Abstract

PLOS ONE  2013 

Screening for Diabetic Retinopathy and Nephropathy in Patients with Diabetes: A Nationwide Survey in Korea

DOI: 10.1371/journal.pone.0062991

Full-Text   Cite this paper   Add to My Lib


This study was performed to identify factors associated with screening for diabetic retinopathy and nephropathy. Data from the Korean National Health and Nutrition Examination Survey between 2007 and 2009 were analyzed. Of 24,871 participants, 1,288 patients diagnosed with diabetes at ≥30 years of age were included. 36.3% received screening for diabetic retinopathy, and 40.5% received screening for diabetic nephropathy during the previous year. Patients living in rural areas, those with less education, those who had not received education about diabetes care, and those who did not receive medical care for diabetes were screened less often for retinopathy or nephropathy. Patients with poorer self-reported health status were screened more often. Occupation, smoking status, and diabetes duration were associated with retinopathy screening. Lower family income was associated with decreased nephropathy screening. Receiving education about diabetes care and receiving medical care for diabetes were significant factors in patients with a shorter duration of diabetes (the significant odds ratio [OR] of not receiving education varied between 0.27 and 0.51, and that of not receiving medical care varied between 0.34 and 0.42). Sociodemographic factors and health-related factors as well as education and medical care influenced screening for diabetic complications among those with a longer duration of diabetes (for retinopathy and nephropathy, the significant OR of living in a rural area varied between 0.56 and 0.61; for retinopathy, the significant OR of current smokers was 0.55, and the p-trend of subjective health status was <0.001; for nephropathy, the significant OR of a monthly household income of <3000 dollars was 0.61 and the p-trends of education and subjective health status were 0.030 and 0.007, respectively). Efforts to decrease sociodemographic disparities should be combined with education about diabetes care to increase the screening, especially for those with a longer duration of diabetes.


[1]  Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047–1053.
[2]  American Diabetes Association (2013) Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care 36: 1033–1046.
[3]  Choi YJ, Kim HC, Kim HM, Park SW, Kim J, et al. (2009) Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998–2005. Diabetes Care 32: 2016–2020.
[4]  Kim TH, Chun KH, Kim HJ, Han SJ, Kim DJ, et al. (2012) Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean National Diabetes Program. J Korean Med Sci 27: 876–882.
[5]  Williams R, Van Gaal L, Lucioni C (2002) Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45: S13–17.
[6]  O'Brien JA, Patrick AR, Caro J (2003) Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 25: 1017–1038.
[7]  Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, et al. (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35: 556–564.
[8]  Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, et al. (2004) Progression of nephropathy in type 2 diabetic patients. Kidney Int 66: 1596–1605.
[9]  Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, et al. (2006) Renal protection in diabetes: role of glycemic control. J Am Soc Nephrol 17: S86–89.
[10]  Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225–232.
[11]  O'Brien JA, Patrick AR, Caro JJ (2003) Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res 3: 7.
[12]  American Diabetes Association (2012) Executive summary: Standards of medical care in diabetes–2012. Diabetes Care 35 Suppl 1S4–S10.
[13]  Do YK, Eggleston KN (2011) Educational disparities in quality of diabetes care in a universal health insurance system: evidence from the 2005 Korea National Health and Nutrition Examination Survey. Int J Qual Health Care 23: 397–404.
[14]  Lim H, Nguyen T, Choue R, Wang Y (2012) Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea. Diabetes Care 35: 2028–2035.
[15]  Yoon JY, Park HA, Kang JH, Kim KW, Hur YI, et al. (2012) Prevalence of dietary supplement use in Korean children and adolescents: insights from Korea National Health and Nutrition Examination Survey 2007–2009. J Korean Med Sci 27: 512–517.
[16]  Lee YH, Bang H, Kim HC, Kim HM, Park SW, et al. (2012) A simple screening score for diabetes for the Korean population: development, validation, and comparison with other scores. Diabetes Care 35: 1723–1730.
[17]  Saadine JB, Fong DS, Yao J (2008) Factors associated with follow-up eye examinations among persons with diabetes. Retina 28: 195–200.
[18]  Shin KH, Chi MJ (2009) Fundus Examination Rate in Diabetics and the Public Health Factors Associated With Fundus Examination Rate. J Korean Ophthalmol Soc AID - 103341/jkos20095091319 [doi] 50: 1319–1325.
[19]  Sundling V, Gulbrandsen P, Jervell J, Straand J (2008) Care of vision and ocular health in diabetic members of a national diabetes organization: a cross-sectional study. BMC Health Serv Res 8: 159.
[20]  Tapp RJ, Zimmet PZ, Harper CA, de Courten MP, Balkau B, et al. (2004) Diabetes care in an Australian population: frequency of screening examinations for eye and foot complications of diabetes. Diabetes Care 27: 688–693.
[21]  Muller A, Lamoureux E, Bullen C, Keeffe JE (2006) Factors associated with regular eye examinations in people with diabetes: results from the Victorian Population Health Survey. Optom Vis Sci 83: 96–101.
[22]  Si D, Bailie R, Wang Z, Weeramanthri T (2010) Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review. BMC Health Serv Res 10: 169.
[23]  Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, et al. (2006) Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med 144: 465–474.
[24]  Brown AF, Gregg EW, Stevens MR, Karter AJ, Weinberger M, et al. (2005) Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 28: 2864–2870.
[25]  Cutler DM, Lleras-Muney A (2010) Understanding differences in health behaviors by education. J Health Econ 29: 1–28.
[26]  Moon S, Shin J (2007) Performance of universal health insurance: lessons from South Korea. World Health Popul 9: 95–113.
[27]  Onakpoya OH, Adeoye AO, Kolawole BA (2010) Determinants of previous dilated eye examination among type II diabetics in Southwestern Nigeria. Eur J Intern Med 21: 176–179.
[28]  Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, et al. (2006) The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 145: 107–116.
[29]  Ramsey F, Ussery-Hall A, Garcia D, McDonald G, Easton A, et al. (2008) Prevalence of selected risk behaviors and chronic diseases–Behavioral Risk Factor Surveillance System (BRFSS), 39 steps communities, United States, 2005. MMWR Surveill Summ 57: 1–20.
[30]  Dervan E, Lillis D, Flynn L, Staines A, O'Shea D (2008) Factors that influence the patient uptake of diabetic retinopathy screening. Ir J Med Sci 177: 303–308.
[31]  Girach A, Manner D, Porta M (2006) Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 60: 1471–1483.
[32]  Fowles JB, Rosheim K, Fowler EJ, Craft C, Arrichiello L (1999) The validity of self-reported diabetes quality of care measures. Int J Qual Health Care 11: 407–412.


comments powered by Disqus

Contact Us


微信:OALib Journal